The Prognostic Relevance of Angiogenesis and Mast Cells in Squamous Cell Carcinoma of the Oesophagus

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2001 Dec 1

PMID 11729214

Citations 79

Authors

G O Elpek

T Gelen

N H Aksoy

A Erdogan

L Dertsiz

A Demircan

N Keles

Affiliations

Soon will be listed here.

Abstract

Aims: Angiogenesis, an important prognostic factor in several tumours, is a complex event mediated by angiogenic factors released from cancer cells and host immune cells. Among the host immune cells, a role has been implicated for mast cells in tumour progression via promoting angiogenesis. Data have been recorded that indicate a correlation between intratumoral neovascularisation, as assessed by microvessel density (MVD), and prognosis in squamous cell carcinoma (SCC) of the oesophagus. However, a correlation between mast cell density (MCD) and either prognosis or angiogenesis has not been delineated yet in this disease. The aim of this study was to investigate the prognostic value of MVD and MCD in SCC of the oesophagus. The correlation between MVD and MCD was also evaluated.

Methods: MVD and MCD were investigated in tumour specimens from 53 patients diagnosed with SCC of the oesophagus. Intratumoral microvessels were stained with anti-CD34 antibody and mast cells with toluidine blue before being measured by light microscopy.

Results: Both MVD and MCD were associated with the depth of wall invasion, lymph node metastasis, and tumour progression (stage). A significant correlation was noted between MVD and MCD values (r = 0.72). The prognosis was significantly worse in patients with high MVD (> or = 92) and high MCD (> or = 18) values. Multivariate analysis indicated that MVD and stage were independent predictors of survival.

Conclusions: These findings support the suggestion that MVD is a reliable prognostic marker in SCC of the oesophagus. Moreover, MCD may have a role in the angiogenesis of these tumours and might be responsible for their aggressive behaviour.

Citing Articles

Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma.

Khromov T, Sitte M, Salinas G, Schminke B, Fischer A, Schliephake H Front Oncol. 2025; 15:1518404.

PMID: 40061903 PMC: 11885139. DOI: 10.3389/fonc.2025.1518404.

Mast cells: key players in digestive system tumors and their interactions with immune cells.

Shu F, Yu J, Liu Y, Wang F, Gou G, Wen M Cell Death Discov. 2025; 11(1):8.

PMID: 39814702 PMC: 11735678. DOI: 10.1038/s41420-024-02258-y.

New insights into the role of mast cells as a therapeutic target in cancer through the blockade of immune checkpoint inhibitors.

Ribatti D Front Med (Lausanne). 2024; 11:1373230.

PMID: 38482531 PMC: 10933100. DOI: 10.3389/fmed.2024.1373230.

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.

Zhang Y, Chen K, Wang L, Chen J, Lin Z, Chen Y Aging (Albany NY). 2023; 15(17):8993-9021.

PMID: 37665670 PMC: 10522377. DOI: 10.18632/aging.205012.

A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis.

Li J, Liu J, Li J, Feng A, Nie Y, Yang Z J Cancer Res Clin Oncol. 2023; 149(13):11647-11659.

PMID: 37405477 PMC: 10465684. DOI: 10.1007/s00432-023-05005-5.

References

Nilsson G, Svensson V, Nilsson K . Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol. 1995; 42(1):76-81. DOI: 10.1111/j.1365-3083.1995.tb03628.x. View

Maeda K, Chung Y, Takatsuka S, Ogawa Y, Onoda N, Sawada T . Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer. 1995; 72(2):319-23. PMC: 2033988. DOI: 10.1038/bjc.1995.331. View

Dethlefsen S, Matsuura N, Zetter B . Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis. 1994; 14(1-6):395-408. View

de Jong J, van Diest P, Baak J . Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest. 1995; 73(6):922-6. View

Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert H . Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res. 1996; 16(4A):2117-21. View

Reed J, McNutt N, Bogdany J, Albino A . Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol. 1996; 23(6):495-505. DOI: 10.1111/j.1600-0560.1996.tb01441.x. View

Tanigawa N, Matsumura M, AMAYA H, Kitaoka A, Shimomatsuya T, Lu C . Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 1997; 79(2):220-5. View

Koide N, Yamanda T, Iida F, Usuda N, Nagata T . Immunohistochemical studies of vascular volume and proliferative activity in squamous cell carcinoma of the esophagus. Surg Today. 1997; 27(2):99-106. DOI: 10.1007/BF02385896. View

Norrby K . Mast cells and de novo angiogenesis: angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF. Inflamm Res. 1997; 46 Suppl 1:S7-8. View

10.

Saeki T, Tanada M, Takashima S, Saeki H, Takiyama W, Nishimoto N . Correlation between expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) and microvessel density in early-stage human colon carcinomas. Jpn J Clin Oncol. 1997; 27(4):227-30. DOI: 10.1093/jjco/27.4.227. View

11.

Takebayashi Y, Natugoe S, Baba M, Fukumoto T, Takao S, Akiba S . Angiogenesis in esophageal squamous cell carcinoma. Oncol Rep. 1998; 5(2):401-4. DOI: 10.3892/or.5.2.401. View

12.

Igarashi M, Dhar D, Kubota H, Yamamoto A, Nagasue N . The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer. 1998; 82(7):1225-32. DOI: 10.1002/(sici)1097-0142(19980401)82:7<1225::aid-cncr3>3.0.co;2-e. View

13.

Lopes J, Hannisdal E, Bjerkehagen B, Bruland O, Danielsen H, Pettersen E . Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Anal Cell Pathol. 1998; 16(1):45-62. PMC: 4617577. DOI: 10.1155/1998/545906. View

14.

Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M . Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res. 1998; 4(9):2195-200. View

15.

Ono M, Torisu H, Fukushi J, Nishie A, Kuwano M . Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol. 1999; 43 Suppl:S69-71. DOI: 10.1007/s002800051101. View

16.

Coussens L, Raymond W, Bergers G, Behrendtsen O, Werb Z, Caughey G . Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999; 13(11):1382-97. PMC: 316772. DOI: 10.1101/gad.13.11.1382. View

17.

Torres C, Wang H, Turner J, Shahsafaei A, Odze R . Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol. 1999; 30(7):753-8. DOI: 10.1016/s0046-8177(99)90135-1. View

18.

Belien J, van Diest P, Baak J . Relationships between vascularization and proliferation in invasive breast cancer. J Pathol. 1999; 189(3):309-18. DOI: 10.1002/(SICI)1096-9896(199911)189:3<309::AID-PATH457>3.0.CO;2-0. View

19.

Seljelid R, Jozefowski S, Sveinbjornsson B . Tumor stroma. Anticancer Res. 2000; 19(6A):4809-22. View

20.

Smith S, Basu P . Mast cells in corneal immune reaction. Can J Ophthalmol. 1970; 5(2):175-83. View